TEMOGET 250MG

Temoget 250mg Capsule contains temozolomide as its active ingredient. This medication falls under the category of Antitumor agents. It is used to treat brain cancer, specifically glioblastoma multiforme in adults and malignant glioma, which includes glioblastoma multiforme or anaplastic astrocytoma in patients over three years of age. Glioblastoma and anaplastic astrocytoma are among the most prevalent and aggressive forms of brain cancer, associated with low survival rates. Anaplastic astrocytoma is managed with Temoget 250mg Capsule or radiotherapy following a biopsy, while Glioblastoma multiforme is treated using a combination of radiotherapy and Temoget 250mg Capsule, which is continued as maintenance therapy.

The common side effects associated with Temoget 250mg Capsule may include nausea, vomiting, dizziness, diarrhea, constipation, hair loss, rashes, fatigue, frequent urination, vision and hearing issues, elevated blood sugar levels, muscle damage, pain in muscles and joints, memory impairment, coordination difficulties, infections, sleep disturbances, and weight loss. It is important to inform your doctor if any of these symptoms are bothersome or persist.

Notify your physician if you have an allergy to Temoget 250mg Capsule or any of its components. Prior to commencing treatment with this medication, inform your physician if you have a hepatitis B infection, anemia, low platelet count, reduced levels of RBC and WBC, blood clotting disorders, or any liver or kidney issues. Your physician will regularly monitor your WBC and platelet counts. This medication should be avoided if you are pregnant or breastfeeding. Both men and women are advised to use birth control to prevent pregnancy and fathering a child.